Scholarly Index
Ross A. Soo
National University Cancer Institute, Singapore; 18,904 total citations; 499 total publications; best world rank #69
National University Cancer Institute, Singapore
18,904Total citations
499Total publications
67H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Lung Cancer Treatments and Mutations | Lifetime | 218 | SG 1 | 99.43 |
| Lung Cancer Research Studies | Lifetime | 249 | SG 1 | 98.95 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 500 | SG 1 | 98.88 |
| Colorectal Cancer Treatments and Studies | Lifetime | 376 | SG 1 | 98.84 |
| Lung Cancer Diagnosis and Treatment | Lifetime | 591 | SG 2 | 98.48 |
| Cancer therapeutics and mechanisms | Lifetime | 659 | SG 3 | 96.77 |
| Lung Cancer Diagnosis and Treatment | 2021-2025 | 69 | SG 1 | 99.09 |
| Lung Cancer Treatments and Mutations | 2021-2025 | 97 | SG 2 | 99.37 |
| Lung Cancer Research Studies | 2021-2025 | 73 | SG 1 | 98.88 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 134 | SG 1 | 98.19 |
| HER2/EGFR in Cancer Research | 2021-2025 | 490 | SG 2 | 91.97 |
| Cancer therapeutics and mechanisms | 2021-2025 | 881 | SG 5 | 73.32 |